EU Agrees Vaccine Delivery Acceleration with Pfizer

EU Agrees Vaccine Delivery Acceleration with Pfizer

The European Commission has agreed with BioNtech-Pfizer to accelerate the delivery of its mRNA vaccine to Member States, starting in a few weeks.

In Q1 of 2022, BioNtech-Pfizer will deliver an additional 20 million vaccine doses with 5 million in January,  5 million in February and 10 million in March. These doses come on top of the already scheduled 195 million doses from BioNTech-Pfizer, bringing the total number of deliveries in Q1 to 215 million.

The EU Commission has also agreed with Moderna on the delivery of additional doses in Q1 of 2022.

This will prove especially helpful for Member States with a short-term need for additional vaccine doses.

In view of the deteriorating epidemiological situation in the European Union over the past months, full vaccination and the roll-out of boosters remain one of the EU’s top health priorities. Taking into account the expected rapid increase in infections due to the Omicron variant, this is now even more urgent than ever.

Countries across the EU are introducing various measure in a bid to fight the latest wave of the pandemic. The Netherlands became the first country to impose a full lockdown on Sunday. In Austria, restrictions have been tightened for those seeking to enter the country without the booster vaccine while in Ireland, a range of new restrictions have been introduced including the closure of all pubs and bars by 8pm.

The Commission continues to work closely with vaccine manufacturers to further accelerate the delivery of vaccine doses to Member States, so that vaccination and boosting can be scaled up over the next weeks and months.

The Commission and Member States have also activated a first option to order over 200 million doses, under the third contract with BioNTech-Pfizer.

This order also covers vaccines adapted to the Omicron variant, should these vaccines become available. By this order, the EU is preparing itself in case adapted vaccines are needed. Deliveries of these over 200 million doses are expected to take place as from Q2 2022.

These doses come on top of the 450 million doses already planned to be delivered in 2022 based on the agreement already signed.

This will bring the total number of deliveries by BioNTech-Pfizer to 650 million doses in 2022.

Image by CDC/Via Unsplash/https://unsplash.com/license

Antoinette Tyrrell is a writer and journalist who started her career in print and broadcast journalism in Ireland. An English and History graduate of the National University of Ireland, Maynooth, she worked for 11 years in corporate public relations for Irish Government bodies in the Foreign Direct Investment and Energy sectors.

She is the founder of GoWrite, a business writing and public relations consultancy. Her work has appeared in a range of national and international media and trade publications. She is also a traditionally published novelist of commercial fiction.

newsletter
Join our mailing list and never miss an update !
Allied Irish Bank Fined €83,300,000 by the Central Bank of Ireland for Tracker Mortgage Breaches

Allied Irish Bank Fined €83,300,000 by the Central Bank of Ireland for Tracker Mortgage Breaches

The Central Bank of Ireland has fined Allied Irish Bank (AIB) €83,300,000 for a series of significant and long-running failings in the treatment of its tracker mortgage customers. A statement from

EU Approves €500 million Finnish Scheme to Aid Companies Affected by War in Ukraine

EU Approves €500 million Finnish Scheme to Aid Companies Affected by War in Ukraine

The European Commission has approved a €500 million scheme to support companies active in the context of Russia's invasion of Ukraine. The scheme was approved under the State aid Temporary

EU Commission Approves Corona Aid for Poland

EU Commission Approves Corona Aid for Poland

The EU Commission approves payments because Poland shows concessions in the ongoing legal dispute. The EU Commission has been blocking the payment of corona aid to Poland for over a